New program aims to keep High-Risk patients on track for cancer prevention
NCT ID NCT07565467
First seen May 13, 2026 · Last updated Jun 23, 2026 · Updated 6 times
Summary
This study tests a program to help people with inherited genetic mutations that raise their cancer risk stick to recommended screening schedules. Researchers will interview 80 women with BRCA or Lynch syndrome mutations and track how well they follow cancer surveillance guidelines. The goal is to lower their risk of developing cancer through better adherence to care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACT-GEN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
MD Anderson Cancer Center
Houston, Texas, 77030, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could lead to better ways to help people with genetic cancer risks stick to screening and reduce their chances of getting cancer.
What could go wrong
This is an early, small study (80 people) that focuses on interviews and standard care, not a new treatment. It may not show clear benefits or apply to everyone.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.